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Alveolar Macrophage-Derived Extracellular Vesicles Inhibit Endosomal 
Fusion of Influenza Virus 
Alveolar macrophages (AMs) and epithelial cells (ECs) are the lone resident lung cells positioned to 
respond to pathogens at early stages of infection. Extracellular vesicles (EVs) are important vectors of 
paracrine signaling implicated in a range of (patho)physiologic contexts. Here we demonstrate that AMs, 
but not ECs, constitutively secrete paracrine activity localized to EVs which inhibits influenza infection 
of ECs in vitro and in vivo. AMs exposed to cigarette smoke extract lost the inhibitory activity of their 
secreted EVs. Influenza strains varied in their susceptibility to inhibition by AM-EVs. Only those 
exhibiting early endosomal escape and high pH of fusion were inhibited via a reduction in endosomal pH. 
By contrast, strains exhibiting later endosomal escape and lower fusion pH proved resistant to inhibition. 
These results extend our understanding of how resident AMs participate in host defense and have broader 
implications in the defense and treatment of pathogens internalized within endosomes.
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Introduction
Influenza respiratory infection is a global health problem affecting people of all ages. Patients who smoke 
or have chronic lung disease have enhanced susceptibility and more severe infection (Arcavi and 
Benowitz, 2004). Influenza is transmitted person-to-person to the proximal airways where it infects and 
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distally to infect ECs in the delicate alveolar spaces responsible for gas exchange. The subsequent 
occurrence of diffuse alveolar damage is a major determinant of the morbidity and mortality associated 
with influenza (Korteweg and Gu, 2008, Taubenberger and Morens, 2008). Current pharmacologic 
treatments and vaccination strategies for influenza have limited applications and efficacy (Dobson et al., 
2015, CDC, 2020), and improved approaches are needed. Naïve individuals require up to 5 days for the 
development of specific T and B cell responses to influenza (Hermans et al., 2018). Therefore, the 
resident immune cells of the lung – alveolar macrophages (AMs) and the alveolar ECs (AECs) that 
comprise the alveolar surface – have an indispensable role in host defense at the early stages of infection. 
An improved understanding of these early innate immune protective mechanisms and how they become 
dysregulated is required to inform future therapeutic approaches.
The AM is uniquely adapted to cope with the distinct and numerous challenges of this microenvironment. 
While resident AMs are now considered to be protective against influenza (Cardani et al., 2017, Kim et 
al., 2013, Kim et al., 2008, Purnama et al., 2014, Schneider et al., 2014), the mechanisms responsible 
remain to be elucidated. Electron microscopic morphometric analysis of human (Fehrenbach et al., 1994) 
and mammalian (Hyde et al., 2004) lungs as well as recent live microscopic studies of the mouse lung 
(Westphalen et al., 2014) demonstrate that there are fewer than one AM per each pulmonary alveolus. 
Moreover, and contrary to traditional notions, live microscopy has suggested that AMs may remain 
relatively stationary in vivo (Westphalen et al., 2014). Taken together, these observations strongly favor 
an important role for paracrine communication in the ability of AMs to protect AECs from influenza 
infection. 
Extracellular vesicles (EVs) represent one mode of paracrine intercellular communication whose 
importance is increasingly appreciated over the last decade. EVs are small (< 1 μm) membrane-delimited 
structures emanating from endosomal or plasma membranes of a wide range of cell types and organisms. 
Surface proteins on EVs can neutralize extracellular antigens or engage surface receptors on target cells 
(Atay et al., 2011, Lima et al., 2009). Additionally, biologically active vesicular cargo (lipids, nucleic 
acids, proteins) can exert intracellular actions in recipient cells upon internalization of EVs (Pitt et al., 
2016, Robbins et al., 2016). The packaging of cargo molecules within EVs serves to protect them from 
degradation in the extracellular space (Zhang et al., 2015). Recent work from our laboratory has revealed 
that cues from neighboring AECs and external stimuli (e.g., soluble mediators, cigarette smoke [CS], and 
lipopolysaccharide) can rapidly modify the number of secreted AM-derived EVs, their cargo, and their 
uptake, with resulting modulation of inflammatory responses within target AECs (Bourdonnay et al., 
2015, Schneider et al., 2017, Speth et al., 2016). These features position EVs as nimble vectors for 
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Despite the public health impact of influenza, little is known about cell communication via EVs in the 
host response to this infection, and EVs secreted from AMs in influenza have not been considered. Using 
in vitro and in vivo models of alveolar communication, we investigated the ability of EVs secreted from 
AMs to inhibit the replication within AECs of a panel of patient-derived influenza viruses. We report here 
that AM-derived EVs are capable of inhibiting only a subset of these influenza strains. Only those strains 
susceptible to inhibition by EVs exhibited defects in endosomal fusion and egress. This differential strain 
susceptibility facilitated the determination that AM-EVs inhibit influenza replication in AECs by 
enhancing endosomal acidification. These studies provide new insights into the mechanisms by which 
AMs promote antiviral defense within the lung, and reveal important characteristics of influenza virus 
that facilitate evasion of the early innate immune response. In addition, these studies reveal an important 
consequence of EV uptake within endosomes which has potential relevance to numerous endocytosis-
dependent pathophysiologic processes beyond influenza. 
Results
Paracrine inhibitory activity of AMs against laboratory strains of influenza infection localizes to 
their secreted EVs. Investigation of the paracrine antiviral activity of AMs requires a sensitive assay of 
influenza replication. A previously-constructed luciferase reporter was inserted downstream of the PA 
segment in the genome of the commonly studied laboratory strain of influenza A/WSN/33 (Tran et al., 
2013). The resulting Luc-WSN/33 generates luminescence with high specific activity from infected cells 
which correlates with virus replication. Luc-WSN/33 infectivity is similar to that of its unmodified wild 
type (WT) counterpart. This permits a sensitive, time-integrated, high-throughput assay of viral 
replication.
We set out to determine the capacity of substances constitutively secreted by AMs to protect ECs against 
influenza infection. We therefore collected conditioned medium (CM) from the mouse MH-S AM cell 
line which we have previously demonstrated readily sheds EVs with functional and structural 
characteristics similar to those of primary AMs (Bourdonnay et al., 2015, Schneider et al., 2017). Luc-
WSN/33 infection was initially assayed in MDCK-SIAT1 cells derived from the standard (Green, 1962) 
MDCK cells, and which were engineered to overexpress α2,6-sialic acid for improved infectivity of 
recent circulating influenza strains (Oh et al., 2008). Indeed, CM from naïve AMs inhibited Luc-WSN/33 
replication in these ECs (Fig 1A,B). This inhibitory effect of CM was localized to ultracentrifugation-
purified EVs contained within CM (Fig 1A,B), and was not shared by the remaining EV-free CM. This 
inhibition of EC influenza replication increased with the dose of AM-EVs provided (Fig 1C), and was not 
the result of decreased EC viability (Appendix Figure S1). This inhibition of influenza replication in ECs 
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macrophages (Fig EV1) both obtained by lavage from naïve C57BL/6 mice and then subjected to 
retroviral immortalization. Finally, EVs isolated from primary rat AMs isolated by lung lavage (Fig 1E) 
and human macrophages differentiated from the THP-1 monocyte cell line (Fig 1F) also demonstrated 
inhibition of influenza replication. These data demonstrate that the inhibitory activity against influenza 
constitutively secreted by AMs localizes to EVs.
AM-EVs inhibit influenza infection of AECs in vitro and in vivo. To confirm that inhibition of 
influenza replication observed in MDCK-SIAT1 ECs (Fig 1) applies to AECs, we tested the effects of 
AM-EVs on the human A549 carcinoma (Fig 2A) and mouse MLE-12 (Fig 2B) AEC lines infected with 
Luc-WSN/33. A dose-dependent effect of AM-EVs against influenza replication was also observed in 
these AEC lines. In separate experiments, we validated the inhibitory effect of AM-EVs on infection of 
MLE-12 AECs with an additional WT laboratory strain PR/8 by more conventionally assessing 
replication using RT-qPCR analysis of the influenza M1 gene (Fig 2C).
Our findings that AM-EVs protect AECs against influenza offers a possible mechanistic explanation for 
previous in vivo studies in multiple species in which depletion of AMs leads to exacerbation of influenza-
related pathology (Kim et al., 2013, Purnama et al., 2014, Kim et al., 2008). We therefore assessed 
whether intrapulmonary delivery of MH-S cell-EVs could rescue the impaired host defense against 
influenza exhibited by mice depleted of AMs following intrapulmonary instillation of clodronate-loaded 
liposomes (Clo) (Fig 2D). As we have reported previously (Zaslona et al., 2014), Clo resulted in 80% 
depletion of AMs at day 2 compared to empty liposomes (Emp) (Appendix Figure S2). At this time point, 
AM-depleted mice were infected oropharyngeally (o.p.) with the PR/8 influenza strain with and without 
co-administration of MH-S AM-EVs. Consistent with previous reports (Tate et al., 2010), Clo depletion 
of AMs resulted in higher viral transcript levels in the lungs of influenza-infected mice compared to mice 
treated with Emp (Fig 2E). Indeed, o.p. treatment with AM-EVs significantly lowered influenza transcript 
levels in lungs from AM-depleted influenza-infected mice, confirming that AM-EVs inhibit influenza 
replication in vivo.
Cell-type specificity, modulation, and characteristics of the AM-EV activity against influenza. That 
AECs were protected against influenza infection by AM-EVs suggests that these EVs contain bioactive 
constituents not elaborated by AECs themselves. To test this hypothesis, EVs were isolated in parallel 
from MH-S AMs and A549 cells, quantified by flow cytometry, and incubated at equal concentrations 
with Luc-WSN/33-infected MDCK-SIAT1 cells (Fig 3A). In contrast to the effects of MH-S-EVs (Fig 
3A, middle bar), the same number of A549-EVs had no significant inhibitory action in MDCK-SIAT1 
cells (Fig 3A, right bar), demonstrating that the inhibitory capacity of AM-EVs against influenza is not a 
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Both experimental and epidemiologic studies have concluded that cigarette smoking (CS) and exposure 
both increase susceptibility to various infections, including influenza (Arcavi and Benowitz, 2004). This 
vulnerability occurs despite intact humoral immunity (Robbins et al., 2006), suggesting that CS 
dysregulates important innate immune responses to influenza. Therefore, we tested the effect of CS 
exposure of AMs on the antiviral function of their secreted EVs using an established in vitro model of CS 
exposure (Phipps et al., 2010), aqueous CS extract (CSE). EVs were isolated from MH-S cells incubated 
with increasing concentrations of CSE, quantified by flow cytometry, and delivered at equal 
concentrations to Luc-WSN/33-infected MLE-12 cells (Fig 3B). CSE treatment of AMs dose-dependently 
attenuated the inhibitory actions of their EVs on Luc-WSN/33 replication in AECs. With exposure of 
MH-S cells to 0.8% CSE, their secreted EVs lost all activity against Luc-WSN/33 replication.
The role of coding and non-coding RNA species in mediating the biological actions of EVs has gained 
substantial interest (Mateescu et al., 2017). We therefore developed a means to selectively deplete RNA 
within AM-EVs to examine the impact of this macromolecule class on the antiviral actions of EVs. 
Subjecting plasma membranes to multiple freeze-thaw cycles is known to result in their permeabilization 
(Mardones and Gonzalez, 2003) and has been shown to provide access to constituents contained within 
EVs (Genschmer et al., 2019). This permeabilization method was used to facilitate incorporation of 
RNase A (Fig EV2) to permit the selective degradation of RNA within EVs. This protocol yielded the 
same number of EVs by flow cytometry, depleted ~90% of total RNA within EVs (Fig EV2, right column 
vs. middle column), and yet failed to abrogate the inhibitory effect of AM-EVs on Luc-WSN/33 
replication in ECs. These data thus implicate non-RNA cargo within EVs as the predominant source of 
activity against influenza. Of note, the vast majority of characterized endogenous inhibitors of influenza 
infection are proteins (Iwasaki and Pillai, 2014). Moreover, we previously demonstrated that CS disrupts 
the packaging of selected proteins into AM-EVs (Bourdonnay et al., 2015). We therefore speculated that 
protein cargo may mediate the ‘anti-viral’ actions of constitutively released AM-EVs, and that CSE might 
result in a reduction in the incorporation of this protein cargo within AM-EVs. 
To identify candidate proteins within AM-EVs that might mediate the inhibitory activity against influenza 
replication within AECs and whose quantity was reduced by CSE, we assessed the differential abundance 
of proteins from control-treated and 0.8% CSE-treated AM-EVs using tandem mass tag mass 
spectrometry (TMT-MS) (McAlister et al., 2014). A schematic outline of the TMT workflow is shown in 
Fig EV3. Of the ~4500 EV proteins identified with high confidence, only 8 proteins exhibiting 
statistically significant differential abundance (-log10 q value > 2, Fig EV3 B, y axis) and >25% absolute 
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method failed to identify any EV protein candidates that could account for the activity of naïve AM-
derived EVs against influenza and whose abundance is reduced by CSE.
Patient-derived influenza isolates exhibit strain-dependent sensitivity to the inhibitory effects of 
AM-EVs. The WSN/33 and PR/8 influenza strains utilized thus far have been subjected to decades of 
adaptation to mice and laboratory cell lines through serial passaging. Consequently, these strains no 
longer cause disease in wild mice or humans (Staeheli et al., 1988, Thangavel and Bouvier, 2014), and 
their virulence mechanisms vary significantly from those of seasonal and pandemic strains isolated from 
infected humans (Brown et al., 2001, Gitelman et al., 1984, Kaverin et al., 1989, Xu et al., 2011, Xu et al., 
2010). Thus, the clinical relevance of results obtained with these laboratory strains requires validation 
from recent patient-derived isolates (listed in Key Resources Table). MDCK-SIAT1 cells were infected 
with these strains in the absence and presence of AM-EVs (Fig 4A), and replication in each condition was 
quantified by RT-qPCR. Replication of the laboratory-adapted strain WSN/33, like PR/8 (Fig 2C), was 
sensitive to inhibition by AM-EVs using this readout. The same was true for three of the patient-derived 
influenza strains (WI/05, WY/03, and CA/09). In contrast, two of the remaining strains (Sing/16 and 
HK/14) were completely resistant to AM-EVs. 
To explore these differences in sensitivity to AM-EVs in a higher-throughput manner, we generated novel 
Luc-expressing patient-derived strains. As schematized in Fig 4B, this was accomplished by combining 
the hemagglutinin (HA) and neuraminidase (NA) from respective patient-derived strains with the 
remaining 6 genome segments of the Luc-WSN/33 strain. These resulting strains were incubated in the 
absence and presence of AM-EVs in MDCK-SIAT1 cells and replication was quantified by luminescence 
(Fig 4C). As with the corresponding WT strains, replication of Luc-expressing WSN/33, WI/05, WY/03, 
and CA/09 strains was sensitive, whereas that of Luc-expressing Sing/16, HK/14, and AA/17 was 
resistant to inhibition by AM-EVs. Because the Luc-expressing strains differ only in their HA and NA 
proteins (Fig 4B), these results indicate that AM-EVs inhibit influenza infection in AECs at a stage that is 
HA- or NA- dependent. 
AM-EVs prevent the fusion of influenza virus with endosomal membranes in susceptible strains. 
The influenza virus replication cycle involves 9 distinct stages defined in ECs (Matsuoka et al., 2013). 
Those stages which depend on HA and NA include plasma membrane binding (HA- and NA-dependent), 
endosomal fusion (HA-dependent), virion assembly (HA- and NA-dependent), and release from the 
plasma membrane (NA-dependent). Non-AM-EVs have previously been reported to bind influenza virus 
extracellularly and thereby prevent infection of ECs (Kesimer et al., 2009, Suptawiwat et al., 2017). By 
contrast, we have previously reported that effects of these AM-EVs on AEC signaling require their 
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influenza and EVs was required for inhibition in our model, MDCK-SIAT1 cells were pre-incubated with 
AM-EVs for 8 h, after which the remaining free EVs were washed away and cells were then infected with 
Luc-WSN/33 (Fig 5A). Inhibition of Luc-WSN/33 infection by AM-EVs was nonetheless evident even 
when delivered prior to virus, thus excluding any direct extracellular interaction. To directly assess 
whether EVs inhibited binding of influenza to the plasma membrane, MLE-12 AECs were co-incubated 
with PR/8 virus and EVs at 4 °C (allowing virion binding but not internalization), and virus bound to 
AECs was quantified by RT-qPCR (Fig 5B) or visualized by immunofluorescence microscopy (Fig 5C); 
no difference in bound influenza virus was detected by either means, indicating that EVs did not inhibit 
binding of virions to the plasma membrane. These results are consistent with close inspection of our Luc-
WSN/33 replication curves generated with or without EVs (example shown in Fig EV4). These 
consistently reveal a significant divergence in replication that occurs exclusively after 1 h post-infection. 
Given that the length of the influenza replication cycle is 6-8 h (Baccam et al., 2006, Frensing et al., 
2016), these data collectively suggest that EVs inhibit an early, intracellular, HA-/NA-dependent stage of 
the influenza replication cycle.
Of the stages previously mentioned, HA-dependent endosomal fusion would fulfill all of these criteria. 
Consistent with observations in other recipient cell types (Mulcahy et al., 2014), we have reported that 
AM-EVs are internalized by AECs into endosomes (Schneider et al., 2017), thus providing EVs the 
opportunity to inhibit the HA-dependent endosomal fusion of susceptible strains. To evaluate this, A549 
cells were co-incubated with WSN/33 (susceptible to inhibition by EVs) and AM-EVs for 40 min. This 
time point was chosen to permit determination of both endosomal and nuclear co-localization prior to the 
synthesis and assembly of new viral genes (Qin et al., 2019, Bayer et al., 1998). The nuclear localization 
of WSN/33 virus (demonstrating successful endosomal fusion) was imaged using immunofluorescence 
confocal microscopy, quantified with FIJI software, and compared to nuclear localization of HK/14-
infected (shown to be resistant to inhibition by EVs in Fig 4) cells treated with AM-EVs. AM-EVs 
reduced the nuclear localization of influenza NP protein in AECs infected with WSN/33 (Fig 5D,E). In 
contrast, AM-EVs failed to alter the nuclear localization of virus in HK/14-infected cells (Fig 5D,F). 
Consistent with these changes in nuclear entry, AM-EVs increased the number of WSN/33 virions within 
late endosomes as measured by NP co-localization with the late endosomal marker Rab7 (Fig 5D,E). By 
contrast, there was no difference in NP/Rab7 co-localization in HK/14-infected cells treated with EVs 
(Fig 5D,F). These data suggest that AM-EVs inhibit the HA-dependent endosomal fusion of susceptible 
strains of influenza in AECs. 
Influenza strain susceptibility to AM-EVs is associated with its timing of endosomal escape and 
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endosomal membranes, it requires priming by host transmembrane serine proteases. Generally, these 
proteases cleave multiple HA subtypes (Bottcher et al., 2006, Chaipan et al., 2009), but host protease 
specificity to certain HA subtypes has been reported (Galloway et al., 2013). However, in the majority of 
cases, this proteolytic activation occurs extracellularly (Skehel and Wiley, 2000) and is artificially 
bypassed in standard in vitro influenza models (including our model) by the addition of TPCK-treated 
trypsin in the viral growth medium. Therefore, the HA strain-dependent intracellular inhibition of 
endosomal fusion by AM-EVs observed in our model is unlikely to be explained by the modulation of 
proteolytic activation of HA by host protein(s). Following proteolytic activation, virions are internalized 
into endosomes which undergo progressive acidification as they transition from early to late endosomes 
(Wiley and Skehel, 1987). This results in a pH-dependent conformational change in HA which facilitates 
its fusion with endosomal membranes, resulting in endosomal escape and subsequent trafficking of the 
viral genome into the nucleus. Each unique HA has a defined pH range of fusion (Costello et al., 2015, 
Galloway et al., 2013, Russier et al., 2016, Singanayagam et al., 2019). 
To investigate whether the divergent susceptibility of these influenza strains to the inhibitory effects of 
AM-EVs is associated with differences in their pH of fusion, the dynamics of their escape from 
endosomes was assayed with timed addition of a high dose of the endosomal acidification inhibitor 
bafilomycin A1 (Baf-A1). Figures 6 A and B show representative examples of endosomal escape assays 
performed on strains susceptible to AM-EVs (grey bars) in direct comparison to strains which resist 
inhibition by AM-EVs (white bars). When treated with high dose Baf-A1 at the time of infection (time 0), 
all strains show >80% inhibition demonstrating that each strain requires some degree of endosomal 
acidification to permit its fusion. Calculated as the slope of change in inhibition across multiple 
experiments (Fig 6C), the EV-susceptible Luc-WSN/33 and Luc-WI/05 strains demonstrated significantly 
more escape from endosomes within 20 min when compared to the EV-resistant strains Luc-AA/17 and 
Luc-HK/14. In contrast, Luc-AA/17 and Luc-HK/14 still exhibited endosomal escape between 60 and 80 
min, yet Luc-WSN/33 and Luc-WI/05 had no detectable escape at this time point (Fig 6D). These data 
demonstrate that the strains susceptible to AM-EV inhibition fuse with endosomes early (within 20 min) 
whereas resistant strains are still fusing with endosomes between 60 and 80 min. Because it is known that 
viruses with a relatively higher fusion pH generally fuse earlier in endosomes (White and Whittaker, 
2016), these data suggest that strains susceptible to inhibition by AM-EVs fusing earlier in endosomes are 
doing so at a relatively higher pH. 
In experiments complementary to Figs 6A-D, we further explored the endosomal fusion characteristics of 
these strains by quantifying their differential sensitivity to inhibition by Baf-A1 and the additional 
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higher pH would tolerate higher doses of these acidification inhibitors. To test this, MDCK-SIAT1 cells 
were pretreated with the indicated doses of Baf-A1 (Fig 6E) or Chl (Fig 6F) prior to co-incubation of the 
inhibitors with the indicated Luc-influenza strains. Strains susceptible (Fig 6E,F – filled symbols) to 
inhibition by AM-EVs (Fig 4) and exhibiting endosomal escape at early time points (Fig 6A-D) all had 
significantly higher IC50 concentrations for both Baf-A1 and Chl when compared to strains resistant 
(open symbols) to AM-EVs which escape endosomes at later time points. Collectively, these data 
demonstrate that influenza strains resistant to inhibition by AM-EVs fuse with endosomes at a lower pH 
than do susceptible strains. Therefore, we hypothesized that internalized AM-EVs lower the pH of 
endosomes outside the optimal fusion pH range of susceptible strains, but within the fusion pH range of 
resistant strains. 
Internalization of AM-EVs enhances the acidification of endosomes. To assay endosomal pH, we 
measured the pH-sensitive change in ratiometric emission spectral intensities of internalized 3 kDa 
dextran conjugated to FITC (FDx) (Davis and Swanson, 2010, Ma et al., 2017). First, a pH standard curve 
for FDx internalized into MDCK-SIAT1 cells was generated. Following overnight incubation with FDx, 
free FDx was washed away, pH was clamped at values chosen to fit the wide pH range of early to late 
endosomes which includes the narrower pH range of HA fusion. Emission (525/50) after sequential 
excitation at the pH-insensitive 445 and pH-sensitive 488 nm wavelengths was collected from these cells 
with confocal live cell microscopy. Distinct intracellular particles were identified and the ratio of their 
emission intensities were recorded using FIJI software and subsequently fit to a standard curve (Fig 7A). 
To detect internalized AM-EVs as particles distinct from FDx, EVs were labeled with a lipophilic deep 
red fluorescent marker (DR-EVs) and incubated with MDCK-SIAT1 cells. Emission from DR-EVs 
internalized into MDCK-SIAT1 cells were readily detected from a separate 700/75 bandpass filter (Fig 
7B) and demonstrated no spectral crossover into the 525/50 filter (used to detect FDx) when excited at 
488 nm (Fig EV5). Because sensitive strains demonstrated endosomal escape between 20-60 min (6 A-C), 
we determined if EVs internalized into endosomes resulted in a measurable endosomal pH change within 
this time range. MDCK-SIAT1 cells were pulsed with FDx with and without DR-EVs for 20 min and 
subsequently chased for 5 min. Images were captured for the ensuing 35 min. 
In MDCK-SIAT1 cells incubated with DR-EVs, endosomes containing EVs exhibited significantly lower 
pH (Fig 7C, center bar) compared to endosomes from control cells (Fig 7C, left bar) and trended toward 
lower pH compared to endosomes without EVs from the same cells treated with DR-EVs (Fig 7C, right 
bar). These data demonstrate that endosomes containing EVs mature to a lower pH range more rapidly 
than control endosomes. Overall, this indicates that AM-EVs may inhibit influenza replication of 
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Discussion
AMs are known to participate in host defense against influenza, but the operative mechanisms remain 
incompletely defined. Among those reported are their ability to sequester virus yet not support productive 
replication, ingest apoptotic bodies, clear cellular debris (Duan et al., 2017), and generate pro-
inflammatory cytokines in response to signals from infected AECs (Seo et al., 2004). However, their 
paracrine elaboration of signals that inhibit viral replication within AECs have received limited attention 
(Cardani et al., 2017) and a role for EVs in this process remains unexplored. In a series of in vitro and in 
vivo studies, we demonstrate that EVs secreted constitutively from naïve rodent and human macrophages 
are taken up within AEC endosomes, where they restrict the fusion of influenza virus, thereby preventing 
its nuclear entry and resulting replication. While this activity was shared by macrophage populations 
residing outside the alveolar compartment, it was not shared by AEC-derived EVs. This activity within 
EVs was also abolished by exposure of the AM to CSE – providing a possible mechanistic explanation 
for the increased susceptibility to and severity of influenza infection recognized in smokers. This 
inhibitory activity was present against clinically relevant, patient-derived influenza strains – including the 
pandemic CA/09 virus – which were sensitive to EV-mediated decreases in endosomal pH. Other strains 
were resistant to this inhibitory effect providing new and clinically relevant insights into the innate 
immune repertoire by which AMs defend the lung against infection.
Endocytosis of extracellular components by AECs is a critical mechanism for preservation of gas 
exchange (Kim and Malik, 2003). We have reported that AECs utilize this pathway to internalize EVs 
that help to restrain inflammation in the challenging lung microenvironment (Bourdonnay et al., 2015, 
Schneider et al., 2017). Among other viruses, influenza has hijacked these endosomal entry pathways in 
order to gain access to the AEC nucleus essential to its replication cycle (Matsuoka et al., 2013). It has 
been argued that the shuttling of host and viral cargo through a common intercellular pathway represents 
coevolution rather than coincidence (Nolte-‘t Hoen et al., 2016). It is therefore not surprising that the host 
has exploited this same pathway to protect against this viral infection, while certain strains of the virus 
may have adapted to circumvent this immune defense mechanism. 
One theme of the limited investigations to date into EVs in influenza has been their ability to prevent 
infection by interfering with the virus binding to the surface of ECs (Kesimer et al., 2009, Suptawiwat et 
al., 2017). In contrast, our results clearly demonstrate an intracellular target (Figs 5, S6) for EVs secreted 
from AMs. To our knowledge, this reduction in endosomal pH (Fig 7) describes a novel functional 
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activation (Admyre et al., 2006, Testa et al., 2010) or inhibition of infection (Maemura et al., 2018) by 
EVs secreted from cells artificially engineered to express specific peptides or microRNAs. Our studies 
reveal that AMs can defend the lung against influenza through secretion of naturally-derived EVs.  EVs 
were previously categorized as representing either of two major subsets, namely microvesicles or 
exosomes. However, it is now understood that there is substantial overlap in the size, biogenesis, and 
markers typical of EV subsets (Mateescu et al., 2017). Our demonstration that this anti-viral activity is 
present within a particular defined population of AM EVs does not exclude the possibility that other 
subsets of AM EVs (isolated with methods distinct from those used in this manuscript) may or may not 
possess this activity. Although our study was focused on influenza, this phenomenon and its resulting 
impact on endosomal pH have broader implications for host defense and treatment against other 
pathogens internalized via endocytosis.
The pH of endosomal fusion of influenza strains is a defining characteristic contributing to their 
transmissibility, virulence, and tropism for certain host species and organs. For example, highly 
pathogenic avian and pandemic influenza strains (e.g. CA/09) are reported to fuse with endosomes at a 
higher pH, whereas seasonal strains typically have a lower pH of fusion (Galloway et al., 2013, Imai et 
al., 2012, Russier et al., 2016).  Focusing on the relationship of this property with virulence, strains that 
escape endosomes relatively early were more capable of evading the effects of the interferon-responsive 
IFITM protein-mediated inhibition of endosomal fusion in ECs (Gerlach et al., 2017). Our study has 
identified a marked divergence in susceptibilities of different strains to innate immune defense via AM-
EVs that is linked to this fundamental property of the virus. In contrast to their resistance to IFITM-
mediated inhibition, our results demonstrate that viruses that escape the endosome comparatively early 
(Fig 6A-D) are susceptible to the innate protective effects of AM-EVs. In this way, previously 
unrecognized paracrine signals from neighboring AMs which can rapidly endow AECs with resistance to 
influenza infection may compensate for a critical gap which exists in the better-studied interferon-
dependent anti-viral state against high-fusion pH strains with considerable epidemiologic impact (e.g. 
highly pathogenic avian, CA/09).
Our results are in line with other studies demonstrating that influenza strains with higher pH of fusion are 
more susceptible to other early innate protective mechanisms in the lung (Singanayagam et al., 2019). 
However, strains with a higher pH of fusion may be more capable of infection and/or replication within 
AMs (Marvin et al., 2017). Whether infection of AMs disrupts their EV-mediated host defense function is 
therefore an important subject for future studies. In addition, we observed that while the more recently-
isolated seasonal H3N2 strains HK/14, Sing/16, AA/17 were resistant to inhibition by AM-EVs, older 















This article is protected by copyright. All rights reserved
not merely a function of its HA subtype. Rather, this result implies that a drift in the H3 subtype prior to 
2014 changed its pH of fusion with a resulting ability to evade this innate immune defense. Precise 
differences between these strain H3 subtypes are therefore also worthy of future investigation.
RNA cargo within EVs has been implicated in many of their biological actions (Mateescu et al., 2017). 
This includes activity against influenza – an RNA virus – targeted by small EV-derived RNAs in 
engineered in vitro models (Maemura et al., 2018) or those derived from other body fluids (Khatri et al., 
2018). Therefore, it was reasonable to consider that the observed ‘anti-viral’ activity of AM-EVs could be 
explained by RNA cargo. We sought to evaluate this possibility by determining if antiviral activity was 
lost when RNase A was incorporated within the EVs by freeze-thaw (Fig EV2). To our knowledge, this is 
a novel experimental approach that may prove useful in other studies investigating the contribution of 
RNA cargo to EV actions. We found that 90% depletion of RNA within AM-EVs failed to abrogate their 
inhibitory effects on influenza replication within ECs. A likely explanation for the lack of involvement of 
RNA relates to the fact that at the early stage of infection at which AM-EVs restrict virions within 
endosomes (40 min, Fig 5), the viral genome is still enveloped and thus unlikely to be available as an 
inhibitory target for, e.g., microRNA.
As an alternate mechanistic direction, we chose to survey the AM-EV proteome in an effort to identify 
candidate proteins whose abundance within EVs was downregulated by CSE treatment of AMs, thus 
explaining the ability of CSE to abrogate the inhibitory activity against influenza (Fig 3B). We also 
envisioned that subsequent informatics analysis would refine the list of candidates based on the identified 
target within ECs – here shown to be the acidification of endosomes. The primary protein involved in the 
acidification of endosomes is the vacuolar ATPase (V-ATPase) (Marvin et al., 2017). Despite the 
identification of ~4500 EV proteins with high confidence, only a very small fraction of these were shown 
to exhibit differential abundance by TMT-MS identification (Fig EV3), none were downregulated by 
CSE, and none of the components of the V-ATPase were identified in either condition with high 
confidence. Of the 8 differentially abundant proteins, 4 are described to influence intracellular redox tone 
which is noteworthy in that redox state determines the pump activity of the V-ATPase (Cipriano et al., 
2008). While this provides a plausible explanation for the loss of ‘anti-viral’ activity in EVs from CSE-
treated AMs, these upregulated candidates shed no light on the ‘anti-viral’ activity present constitutively 
within EVs derived from naïve AMs. One obvious limitation to the approach employed herein is that it 
will not identify proteins within EVs that are functionally inactivated (e.g. oxidation) by CSE, but whose 
abundance within EVs is preserved. It also remains possible that the baseline activity of EVs reflects the 
actions of multiple proteins, and/or lipids. These results underscore the complexity of possibilities and the 
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Newer vaccine formulations incorporate adjuvants specifically based on their ability to activate innate 
immune pathways, which subsequently enhance humoral responses (Levitz and Golenbock, 2012). Thus, 
this study on fundamental innate protective mechanisms and how they become dysregulated has the 
potential to inform both the development of new therapeutic approaches as well as their eventual 
incorporation into optimal vaccination strategies. If the responsible cargo within EVs is ultimately 
identified, then a translational application of this study would be the encapsulation of this lone cargo 
within synthetic liposomes for treatment against applicable pathogens. Alternatively, if the activity of 
EVs described herein is not attributable to lone cargo, there are numerous applications of cell-derived 
EVs which are currently undergoing clinical trials for the treatment of various diseases (Wiklander et al., 
2019).
Materials and Methods
Reagents and Tools Table
Mice and rats
All animal experiments were performed according to National Institutes of Health guidelines for the use 
of experimental animals with the approval of the University of Michigan Committee for the Use and Care 
of Animals.  Female C57BL6/J mice and Wistar rats were housed in ventilated, monitored cages. At least 
4 mice per experimental group, 8 weeks of age were used in these experiments. Two rats per experimental 
group were used in these experiments. 
Cell lines 
MDCK Siat-1 (Arnold S. Monto at The University of Michigan School of Public Health) and 293T 
(ATCC CRL-3216) cells were cultured in DMEM with 10% FBS and penicillin/streptomycin. A549 
AECs (ATCC CCL-185) and MH-S AMs (ATCC CRL-2019) were cultured in RPMI 1640 supplemented 
with 10% FBS and penicillin/streptomycin. MLE-12 AECs (ATCC CRL-2110) were cultured in HITES 
medium which contained F-12 K medium with L-glutamine (Gibco), 2% FBS, 0.5% ITS liquid 
supplement (insulin, transferrin, sodium selenite (Sigma)), 2.5 mg transferrin (Sigma), 5mM HEPES 
(Gibco), 10 nM β-estradiol (Sigma), 10 nM hydrocortisone (Sigma), and penicillin/streptomycin. Human 
THP-1 monocytes (ATCC TIB-202) were maintained in 10% FBS-supplemented RPMI. For THP-1 
differentiation into macrophages (Volgers et al., 2017), cells were stimulated for 72 h with 100 nM 
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AMs were J2 retrovirally-immortalized using previously published methods (Zhou et al., 2008) with some 
modifications. The source of J2 retrovirus was the CM of AMJ2-C11 cells (ATCC CRL-2456) clarified 
through centrifugation (3000 x g for 15 min @ 4 °C) and filtered through a 0.45 μm membrane 
(Millipore). Primary AMs and peritoneal macrophages were isolated by lung and peritoneal lavage of 8 
week old female C57BL/6J mice and cultured overnight in RPMI with 10% FCS and 
penicillin/streptomycin. Macrophages were then washed and cultured in the clarified J2 retrovirus-
containing AMJ2-C11 CM for 24 h. Excess virus was washed away and cells were cultured in fresh 
RPMI with 5% FCS, 5 mM HEPES, and penicillin/streptomycin for 1 day. This process was repeated 
once more, and cells were then cultured back in RPMI with FCS and HEPES until immortalization was 
observed approximately 2 weeks later. These immortalized primary mouse macrophages were 
subsequently maintained in RPMI plus 10% FBS and 5 mM HEPES and used for EV isolation within 5 
passages. 
Primary rat AM isolation
Resident AMs were obtained by lavage of the lungs of pathogen-free 125-150g female Wistar rats 
(Charles River) (Bourdonnay et al., 2015, Speth et al., 2016). AMs isolated by lung lavage were pelleted 
by centrifugation (500 x g for 5 min @ 4°C) and resuspended in serum-free RPMI to a final concentration 
of 1 x 106 cells/ml. AMs were adhered to plastic cell culture plates for 1 h and then washed with PBS to 
remove non-adherent cells and products liberated from AMs by their activation following adherence to 
plastic. AMs were placed in fresh, serum-free RPMI and incubated for 16 h prior to isolation of their EVs. 
Generation of Viruses
To generate the Luc-WSN/33 strain, a nanoluciferase was previously cloned downstream to the influenza 
WSN/33 PA genome segment (pBD-PA-SWAP-2A-NLuc) yielding the Luc WSN/33 strain with high 
specific activity, competent replication, and equal virulence to its WT counterpart (Tran et al., 2013). 
Molecular clones of Luc-WSN/33 and all patient-derived WT viruses listed in Key Resources Table were 
generated by RT-PCR amplification of insertion of all eight genomic segments into individual pHW2000 
plasmids (Robert G. Webster; St. Jude Children’s Research Hospital) (Hoffmann et al., 2000, Hoffmann 
et al., 2001). Using standard reverse genetics methods for the generation of reassortant influenza viruses 
(Hoffmann et al., 2002), novel Luc-viruses were recovered after transfecting co-cultures of 293T and 
MDCK-SIAT1 cells (2:1 ratio, 12 well plates) with 6 plasmids containing individual gene segments from 
Luc-WSN/33 (including pBD-PA-SWAP-2A-NLuc) and 2 plasmids containing the remaining HA and 
NA segments corresponding to individual influenza strains (see Key Resources Table and Figure 4C). 
Transfections were performed with 0.5 μg of each plasmid using Fugene HD (Promega) according to the 
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MDCK-SIAT1 cells at MOI 0.01 for the generation of working P1 viral stocks whose titers were 
determined with the TCID/50 method. Corresponding patient-derived WT strains used for data in Fig 4A 
were recovered, transfected, expanded, and quantified using the same methods in parallel with Luc-
expressing strains. As indicated in Key Resources Table, the WT PR/8 and WSN/33 laboratory strains 
were obtained from ATCC.
Reagents 
The two lots of CSE used in these studies were generated by bubbling the smoke from five 2R4F 
cigarettes, secured to the inlet port of a glass impinger (Ace Glass, Vineland, NJ), into a reservoir 
containing 50 ml of RPMI. Aliquots of this CSE stock were frozen at -80°C and subjected to exactly 1 
freeze-thaw cycle. CSE prepared with these methods and used at concentrations and incubation times in 
these studies do not affect the viability of AMs (Phipps et al., 2010). Baf-A1 and Chl were purchased 
from Sigma. Baf-A1 was dissolved in 100% DMSO. Working dilutions of Baf-A1 and corresponding 
untreated controls were diluted to a final concentration of 0.1% DMSO with cell culture medium. pH 
clamping buffers contained 130 mM KCl, 15 mM HEPES, 15 mM MES, 2 mM MgCl2, 10 μM 
valinomycin (Sigma), 10 μM nigericin (Sigma), and 0.02% NaN3 (Davis and Swanson, 2010).
EV isolation and quantification
EVs were isolated and quantified from the CM of MH-S AMs, primary rat AMs, immortalized primary 
mouse AMs, or THP-1 monocyte-differentiated macrophages using methods we have previously 
published (Bourdonnay et al., 2015, Schneider et al., 2017). AMs grown in serum-containing RPMI were 
passaged into serum-free RPMI onto polystyrene flasks overnight. Primary rat AMs were maintained in 
serum-free RPMI as above. For THP-1 macrophages, following the 72 h differentiation step above, 
adherent cells were washed and placed in serum-free RPMI for an additional 16 h to collect EVs. To 
assess changes in EV function in response to CSE, MH-S cells were adhered to culture dishes in serum-
containing RPMI overnight. Cells were subsequently washed and treated with increasing concentrations 
of CSE diluted in serum-free medium for 20 h. In all cases, EVs were subsequently isolated from the 
resulting CM by serial centrifugation (500g x 5 min then 2500g x 12 min at 4 °C) followed by pelleting 
with ultracentrifugation (17,000g x 30 min at 4 °C). EV pellets were washed twice with a maximum 
volume of PBS between additional ultracentrifugation spins and ultimately resuspended in PBS. Our lab 
has published that AM-EVs isolated with this method are shed from the plasma membrane and express 
phosphatidylserine on their outer surface (Bourdonnay et al., 2015) consistent with larger EVs previously 
termed ‘microvesicles’ (Mateescu et al., 2017). EVs were subsequently quantified using a BD FACS 
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quantification, the flow cytometer cell was cleared with 10% bleach for 10 min followed by separate 
aliquots of 0.22 μm-filtered PBS until events in the EV gate were detected at less than 2 per second. The 
quantity of these events detected in filtered PBS were subtracted from each EV measurement. Events 
counted as EVs exhibited a characteristic size range in reference to fluorescent calibration beads (1.0 μm, 
Invitrogen) and were distinct from machine noise (identified as detected events common to 0.22 μm-
filtered PBS with lower side scatter values than EVs (Schneider et al., 2017)). All EVs for in vitro and in 
vivo studies were utilized after exactly one freeze-thaw cycle following storage at -80 °C for less than 3 
months. Labeling of EVs for endosomal pH experiments was performed with CellMask Deep Red Plasma 
membrane Stain (ThermoFisher) according to the manufacturer’s instructions with some modifications as 
we have published previously for labeling AM-EV membranes with a fluorescent lipophilic dye 
(Schneider et al., 2017). Following the incubation of pelleted EVs with the Deep Red stain, excess dye 
was quenched with an equal volume of 0.22 μm-filtered FBS, and aggregates were removed by 
centrifugation (2500g x 12 min at 4 °C). The resulting supernatant containing labeled EVs was washed 
twice with PBS between additional ultracentrifugation spins. 
RNA depletion within EVs 
Three groups of EVs were isolated from equal volumes of MH-S CM, subsequently treated with RNase A 
(Roche, 10 μg/ml) for 30 min to deplete RNA outside EVs, and ultimately subjected to gentle 
permeabilization by repeated freeze-thaw cycles at -80 °C to permit RNase A entry into EVs. This 
permeabilization occurred before or after addition of an RNAse inhibitor (150 U/ml, Applied Biosystem) 
in the different conditions. EVs in each condition were subsequently re-pelleted with ultracentrifugation, 
washed twice with PBS, resuspended directly in RL Buffer (Total RNA Purification Micro Kit; Norgen 
Biotek), and EV RNA was isolated using according to the manufacturer’s instructions. RNA was 
quantified in each EV condition with Agilent Bioanalyzer 2100 and TapeStation Analysis Software 3.1.1 
(Agilent Technologies). 
Differential abundance of proteins within AM-EVs treated with CSE
EVs were collected from MH-S AMs cultured in 0% CSE or 0.8% CSE in serum-free RPMI. EVs from 
both conditions were resuspended in 8M Urea + 25mM HEPES lysis buffer followed by high sensitivity 
protein estimation (Sigma). 22 μg of protein from each condition in triplicate was labeled with the 
Tandem Mass Tag 6-plex labeling kit (ThermoFisher) according to the manufacturer’s instructions. Prior 
to their identification, labeled proteins were precipitated with trichloroacetic acid/acetone and separated 
using nano-ultra high pressure liquid chromatography. For identification, MS3 analysis (McAlister et al., 
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on their differential expression in control EVs vs. EVs isolated from 0.8% CSE-treated AMs. Data were 
analyzed with Proteome Discoverer (v2.1 Thermo Fisher) and initial spectra were searched against the 
Uniprot mouse proteome database (modified 2018 07-27, 53857 sequences). Identified proteins and 
peptides had a false discovery rate of <1%. Paired t-test with Benjamini-Hochberg multiple testing 
correction (Benjamini and Hochberg, 1995) was used on spectra to identify statistically significant (p < 
0.05) differences in abundance.
Assessment of influenza replication in Luc- and WT strains 
Viral infections in MDCK-SIAT1 and A549 cells were performed in viral growth medium (VGM) which 
contained DMEM, 2 μg/ml TPCK-treated trypsin (Sigma), 0.1875% BSA (Sigma), 25 mM HEPES, and 
penicillin/streptomycin. Infections in MLE-12 cells were performed in serum-free HITES medium 
supplemented with 2 μg/ml TPCK-trypsin, 0.1875% BSA, and additional HEPES to a final concentration 
of 25 mM. ECs were seeded into 96-well plates in serum-containing medium and grown overnight to a 
final concentration of ~20k cells/well. Cells were subsequently washed, infected with Luc-strains in 
VGM and Enduren luciferase substrate (manufacturer’s recommended working concentration) (Promega) 
with and without AM-EVs or inhibitors. Luciferase activity indicated viral replication and was quantified 
from individual wells at 90 second intervals while maintaining cells at 37°C and 5% CO2 with a Synergy 
H1 Luminescence Reader with CO2 regulator (BioTek) until the first condition reached the end of the 
exponential growth phase (at least 16h for all experiments and strains) or until the replication time 
reached 24 h. AUC measurements of luminescence curves were calculated with Prism 8 software for 
individual wells. In selected plates, cells were subsequently incubated with Cell Titer-Glo (Promega) to 
determine cell viability according to the manufacturer’s instructions. The final luminescence value at the 
end of the replication assay was recorded prior to the addition of Cell Titer-Glo reagent and subtracted 
from the cell titer luminescence reading for each individual well. For WT strains, MLE-12 cells were 
grown overnight in 12 well plates to 90% confluency. Cells were washed, and incubated with WT strains 
with and without EVs for 12 h. All experiments were performed at a multiplicity of infection (MOI) of 1 
and with a EV:cell ratio of 1 unless otherwise specified in figure legends.
Influenza infection of AM-depleted mice
Clo-loaded liposomes were generated in the laboratory of Dr. Nico van Rooijen according to a previously 
established method (van Rooijen and van Kesteren-Hendrikx, 2003) (Liposoma BV). On day 0, 50 μl of 
clodronate liposomes (or control empty liposomes) were administered o.p. to 8 week old anesthetized 
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modified Wright-Giemsa-stained (Diff-Quik, American Scientific Products) cells subjected to cytospin. 
On day 2, mice were given 50 plaque-forming units of PR/8 virus (ATCC) resuspended in 50 μl of sterile 
PBS with or without AM-EVs (2e5/μl). This concentration is similar to that of other published reports 
utilizing intrapulmonary instillation of EVs (Bourdonnay et al., 2015, Genschmer et al., 2019). On day 3, 
mice were sacrificed, lungs perfused with cold PBS, and snap frozen in liquid nitrogen. Both lungs from 
each mouse were subsequently thawed in tubes containing Trizol (Invitrogen), minced briefly on ice, and 
homogenized using a tissue bead beater (MP Bio) and lysing matrix beads (MP Bio).
RT-PCR
Total RNA from mouse lungs or MLE-12 AECs grown on 12-well plates was isolated through Trizol 
extraction and purified in RNA Easy Qiagen columns according to the manufacturer’s instructions. 
Influenza replication was quantified using the Taqman RNA-to-Ct 1-Step kit (Applied Biosystems) on an 
ABI Prism 7300 Thermocycler (Applied Biosystems). Relative gene expression of influenza M gene was 
determined using the ΔCt method with β-actin as the reference gene. Primers and probes used are listed in 
Key Resources Table. 
Immunofluorescence microscopy
Human A549 or MLE-12 AECs were plated overnight at a density of 100k cells/well on fibronectin-
(Sigma; 1.25ug/cm2) coated #1.5 coverglass chamber slides (Lab-Tek, Nunc). Cells were washed, co-
incubated for 40 min with WT virus (WSN/33 or HK/14; MOI = 1) with and without AM-EVs in VGM. 
Cells were washed with PBS, fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100 
(except in plasma membrane binding experiments shown in 5C), and incubated in blocking solution 
containing 0.3M glycine, 2% BSA, and 5% goat serum in PBS. Primary staining was performed as 
sequential overnight incubations at 4°C first using rabbit anti-Rab7 for late endosomes (Cell Signaling 
Technologies, #9367) (1:100) or rabbit IgG isotype control (Abcam, ab171870, 1:100) followed by 
mouse anti-influenza NP (Abcam, ab20343) (2.89 ug/mL) or mouse IgG isotype control (Abcam, 
ab18415) in blocking solution. Secondary staining was performed sequentially with Alexa Fluor 
(Invitrogen) 488 anti-mouse IgG (1:1000) followed by Alexa Fluor 568 anti-rabbit IgG (1:1000) for 45 
min each at RT. Cells were covered with DAPI Prolong Gold mounting mediu m (Invitrogen). Images 
were taken from an SP5X inverted confocal microscope and analyzed with Application Suite Advanced 
Fluorescence Software (Leica). Each image was captured with laser intensities and amplifier gains set to 
avoid pixel saturation. Fluorophores were independently excited and detected sequentially. Individual 
images were captured with a 100x objective with 1.4 numerical aperture, oil immersion, and pinhole set 
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created with FIJI software (National Institutes of Health). Virus nuclear localization was quantified as a 
ratio of NP intensity within the DAPI region divided by total cellular NP intensity. Co-localization of 
influenza within late endosomes was quantified as the Manders co-localization coefficient of NP and Rab-
7 staining using the coloc 2 plugin in FIJI. 
Endosomal escape assay and acidification inhibitor IC50 determination
MDCK-SIAT1 cells were plated at 90% confluency on flat-bottom, opaque 96-well plates and cultured 
overnight in DMEM plus 10% FBS. For the endosomal escape assay, Luc-expressing strains were bound 
in VGM on ice for 45 min. Cells were washed and placed in fresh VGM containing the EnduRen 
substrate. Synchronized uptake of bound virions was then initiated at time 0 by placing plates at 37 °C 
and 5% CO2. At the specified times indicating the duration of 37 °C incubation, wells were supplemented 
with Baf-A1 (Sigma) to a final concentration of 10 nM. After the time 80 min Baf-A1 addition, the cells 
were placed in the luminometer (set at 37 °C and 5% CO2) and replication was determined by 
luminescence measurements for 4 h and 40 min (6 total h of infection time at 37 °C) to limit the assay to 
one replication cycle (Baccam et al., 2006, Frensing et al., 2016). For IC50 determination, MDCK-SIAT1 
cells were plated overnight, subsequently washed, and pre-incubated with Baf-A1 or Chl at the 
concentrations indicated in figure legends for 30 min. Subsequently, cells were co-incubated with the 
same corresponding inhibitors and concentrations in VGM plus EnduRen substrate and Luc-expressing 
influenza strains, and replication was assessed by continuous luminescence. Each plate contained (escape 
assay) 2 strains with each time point Baf-A1 addition performed in 5 replicate wells, or (IC50 
determination) 4 strains with each dose of inhibitor performed in triplicate wells. 
Endosomal pH standard curve generation and measurement
Endosomal pH was determined with live cell measurement of the pH-sensitive change in ratiometric 
excitation spectral intensities of internalized 3 kDa FDx (Thermo Fisher) (Davis and Swanson, 2010). 
MDCK-SIAT1 cells were plated overnight on uncoated 35mm #1.5 coverglass dishes (MatTek 
Corporation). Cells were subsequently pulsed for 20 min with 3 kDa FITC-dextran with or without DR-
EVs followed by a 5 min chase with PBS. Cells were imaged using a Nikon A1R inverted confocal 
microscope with a 63x objective and oil immersion. Ratiometric fluorescence of FDx was acquired with 
sequential excitation of the pH insensitive (445 nm) and pH sensitive (488 nm) wavelengths followed by 
emission collection with a single photomultiplier tube using a 525/50 bandpass filter. DR-EV 
fluorescence was acquired with 647 nm excitation and emission was collected with a 700/75 filter. All 
images were captured within 35 min from the end of the 5 min chase period. Laser intensities and 
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internalized FDx alone were maintained in a pH clamping buffer (pH range 5.0 - 7.0, contents listed 
above) for 20 min prior to imaging. For standard curve generation and pH measurement, post-acquisition 
analysis of the emission intensities of the distinct intracellular particles (DR+ EVs, FDx+ endosomes) and 
their colocalization was performed using FIJI software. From confocal images of a single focal plane 
(213x213 μm; 512x512 pixels) in the 647ex/700em channel, DR+EVs were selected as regions of interest 
(ROIs) defined by a size range between 0.2 to 5.0 μm and a constant intensity threshold across all 
experiments. FDx+ endosomes were defined as separate ROIs in the same manner from the 445ex/525em 
channel and used to select endosomes within both 525em (445ex and 488ex) images. DR+EV ROIs were 
then applied to both 525em images and FDx+ emission intensities within (DR+EV and FDx+ colocalized 
endosomes) and outside (FDx+ endosome) these ROIs were separately measured, recorded as a ratio 
(488ex:445ex), and applied to the standard curve to return the pH value. Individual data points reported 
are the average emission ratios of all analyzed endosomes within each condition within 1 hpf. At least 5 
images containing ~20 cells per hpf were taken for each condition per experiment.
Quantification and Statistical Analysis
For transparency and to display variation in control conditions for normalized data, all individual data 
points across multiple experiments for each condition are displayed in figures unless otherwise specified. 
However, unless otherwise specified, the statistical comparisons presented are between the means of 
replicates within each experimental conditions for an individual experiment using one-way ANOVA with 
Tukey’s multiple comparisons post hoc analysis (or Student’s t test where appropriate). Half maximal 
inhibitory concentration (IC50) curves were generated (non-linear fit, [inhibitor] vs. normalized response 
– Variable slope function) and returned values for mean IC50, standard error, and degrees of freedom for 
each strain. These input values were used for the one-way ANOVA multiple comparisons calculation to 
determine statistical significance between the IC50 values of each strain. All data were analyzed using the 
Prism 8.0 statistical program from GraphPad software. The following symbols were used to display p 
value ranges in all main and supplemental figures: * p value of < 0.05, ** p < 0.01, *** p < 0.001, **** p 
< 0.0001.
Data Availability 
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the 
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Figure legends
Figure 1. Paracrine inhibitory activity of AMs against laboratory strains of influenza infection 
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A, B. MDCK-SIAT1 cells co-incubated with Luc-WSN/33 and MH-S CM fractions. Replication was 
quantified by luminescence. (A) Replication curves display average luminescence reads from 5 
wells per condition (measured at 7.5 min intervals - displayed here at 30 min intervals) from 1 
experiment representative of 7 independent experiments. (B) Mean calculated area under the 
luminescence curves (AUC) for individual wells normalized to the corresponding mean of the 
control condition from these 7 experiments.
C. Luc-WSN/33 replication in MDCK-SIAT1 cells incubated with flow cytometry-quantified MH-S 
AM-EVs at specified EV:cell ratios.
D. Luc-WSN/33 replication in MDCK-SIAT1 cells incubated with CM fractions of J2 retrovirus-
immortalized primary mouse AMs. 
E. Luc-WSN/33 replication in MDCK-SIAT1 cells incubated with primary rat AM-derived EVs. 
F. Luc-WSN/33 replication in MDCK-SIAT1 cells incubated with human THP-1 macrophage-
derived EVs. 
Data information: Luc-WSN/33 replication in each condition represented by mean luminescence AUC for 
individual wells normalized to the mean of the control condition from 3 (C-E) and 4 (F) independent 
experiments. Error bars = SD. One-way ANOVA (B-D, F) and unpaired Student’s t-test (E) (* p value of 
< 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).
Figure 2. AM-EVs inhibit influenza replication in AECs in vitro and in vivo. 
A, B. Luc-WSN/33 replication co-incubated with MH-S EVs was assessed in (A) human A549 and (B) 
mouse MLE-12 AECs. Data represent mean luminescence AUC from individual wells 
normalized to the mean of the corresponding control condition from 3 independent experiments. 
C. MLE-12 AECs incubated with MH-S EVs infected with PR/8 influenza. Replication was 
quantified by RT-qPCR at 12 h post infection. Data represent mean M gene transcripts 
normalized to β actin from 3 independent experiments. 
D.  Schematic outline for AM depletion in lungs of mice with o.p. Clo followed by intrapulmonary 
delivery of AM-EVs PR/8 infection. 
E Total lung RNA was isolated from mice on day 1 post infection and virus was quantified by RT-
qPCR. Data represent mean M gene transcripts from individual mice normalized to β actin from 3 
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Data information: Error bars = SD. One-way ANOVA (A, B) and unpaired Student’s t-test (C) (* p value 
of < 0.05, *** p < 0.001, **** p < 0.0001). For (E), the comparison between conditions was performed 
with one-way ANOVA (multiple comparisons) on values obtained from individual mice across all 
experiments. 
Figure 3. Cell-type specificity, modulation, and characteristics of the AM-EV activity against 
influenza. 
A. EVs isolated from MH-S AMs and A549 AECs were co-incubated in parallel with Luc-WSN/33 
(MOI = 0.5) in MDCK-SIAT1 cells. Data represent mean luminescence AUC from individual 
wells normalized to the mean of the corresponding control condition from 3 independent 
experiments. 
B. EVs isolated from MH-S cells treated with increasing concentrations of CSE were co-incubated 
with Luc-WSN/33 in MLE-12 cells. Data represent mean luminescence at 12 h post infection 
from individual wells normalized to the mean of untreated AM-EVs from 3 independent 
experiments per condition. 
Data information: Error bars = SD. One-way ANOVA (A, B) (* p value of < 0.05, ** p < 0.01, *** p < 
0.001, **** p < 0.0001).
Figure 4. Patient-derived influenza isolates exhibit strain-dependent sensitivity to the inhibitory 
effects of AM-EVs. 
A. MLE-12 AECs co-incubated with the listed WT strains (MOI = 0.4) plus AM-EVs (grey bars, 
EV:cell = 1). Data represent mean M gene transcripts at 12 h post infection relative to the mean 
of the corresponding untreated strain (white bars), each normalized to β actin from 2-4 
independent experiments per strain.
B. Schematic flow diagram of the generation of luciferase-expressing patient-derived influenza 
viruses. The generation of the novel Luc-CA/09 strain is shown as a representative example. 
C. MHS EVs were co-incubated with the listed Luc-expressing strains plus AM-EVs (grey bars, 
EV:cell = 2) in MDCK-SIAT1 cells. Data represent mean luminescence AUC from individual 
wells normalized to the means of the corresponding untreated strain (white bars) from 3 
independent experiments per strain. 
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Figure 5. AM-EVs prevent the fusion of influenza virus with endosomal membranes in susceptible 
strains. 
A. MDCK-SIAT1 cells were pretreated with MH-S EVs (EV:cell = 2, ‘EV pretreat’) or control for 8 
h, washed, and subsequently incubated with Luc-WSN/33 (MOI = 1). Data represent mean 
luminescence AUC from individual wells normalized to the means of the control condition from 3 
independent experiments. 
B, C. MLE-12 cells were incubated with WT PR/8 + AM-EVs at 4 °C (to permit surface binding but not 
entry) for 1 h, washed, and processed for (B) RNA isolation or (C) immunofluorescence 
microscopy. (B) Data represent mean M gene transcripts relative to the means of the corresponding 
untreated condition, each normalized to β actin from 3 independent experiments. (C) Cells in both 
conditions were fixed and stained with anti-NP or isotype control Ab. Images are representative of 
two independent experiments. Scale bars = 50 μm
D. A549 cells were incubated with WSN/33 or HK/14 + AM-EVs for 40 min, washed, fixed, and 
permeabilized. Cells were subsequently stained with Anti-NP (green), Anti-Rab-7 (purple) Abs, 
and DAPI (blue). Images shown are representative of 8 independent experiments. Scale bars = 5 
μm
E, F. Co-localization analysis of (E) NP:DAPI and (F) NP:Rab7 for each condition was performed on Z-
stack confocal images images of WSN/33 (black) or HK/14 (red) infected A549s. Data represent 
the mean NP:DAPI co-localization ratios and the mean NP:Rab7 Mander’s co-localization 
coefficient for individual cells from these 8 experiments. 
Data information: Error bars = SD. One-way ANOVA (B) and unpaired Student’s t-test (A, E, F) (* p value 
of < 0.05, **** p < 0.0001).
Figure 6. Influenza strains susceptible to inhibition by AM-EVs escape endosomes early and are 
resistant to inhibitors of endosomal acidification. 
A-D. Replication assessed by luminescence following 10 nM Baf-A1 addition at the indicated times 
following synchronized uptake of bound Luc-expressing virions. (A, B) Shown are examples from 
1 experiment representative of a total of 3-11 independent experiments per strain. Data represent 
mean luminescence AUC normalized to the mean of the corresponding strain incubated in 0.1% 
DMSO (dashed line). (C, D) The kinetics of endosomal escape by Luc-WSN/33 and HK/14 strains 
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min. Data represent mean slope (change in % inhibition/time interval) from 5 wells per plate from 
3-11 independent experiments. 
E, F. Shown are dose response curves (left) and corresponding IC50 values (right) for effects of the 
endosomal acidification inhibitors (E) Baf-A1 and (F) Chl on replication of Luc-expressing strains. 
Curves display mean luminescence AUC expressed as a percentage of replication of corresponding 
strains in control conditions from 3-5 independent experiments (mean of 3 wells per condition) for 
each strain and inhibitor concentration. Bar graphs depict mean IC50 values from these 
experiments. 
Data information: Error bars are SD (A, B) and SEM (C-F). One-way ANOVA (C-F) (* p value of < 0.05, 
** p < 0.01, *** p < 0.001, **** p < 0.0001).
Figure 7. Internalization of AM-EVs enhances the acidification of endosomes. 
A. Data are mean 525em ratio from 488/445 nm excitation intensities of internalized FDx particles vs. 
pH of clamping buffer fit to a standard curve from two independent experiments. 
B. Representative images of PBS- and DR-EV-treated MDCK-SIAT1 cells. Scale bars for full size 
images = 50 μm. Scale bars for cropped images = 10 μm. FDx particles are shown green and DR-
EV particles are shown purple. White arrows are FDx endosomes containing DR-EVs.  
C. Measured pH of FDx endosomes in PBS- (left bar) and DR-EV-treated (right bar) MDCK-SIAT1 
cells. The pH of FDx endosomes containing DR-EVs in DR-EV-treated cells (middle bar) 
(corresponding to white arrows in Fig 7B). Data are the means of individual data points 
representing the average calculated pH of each endosome population within 1 hpf in each of 5 
independent experiments. 
Data information: Error bars = SD. One-way ANOVA (C) (** p value of < 0.01).
Expanded View Figure Legends
Figure EV1. EVs isolated from immortalized mouse primary peritoneal macrophages inhibit 
influenza replication.
MDCK-Siat1 cells were co-incubated with Luc-WSN/33 and EVs isolated from immortalized primary 
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luminescence AUC for individual wells normalized to the mean of the control condition from 4 
independent experiments. 
Data information: Error bars = SD. Unpaired Student’s t-test (**** p value of < 0.0001).
Figure EV2. AM-EV inhibitory activity against influenza is not sensitive to RNase A
Schematic outline of the strategy to deplete RNA within EVs. Three groups of EVs were isolated from 
equal volumes of MH-S CM, subsequently treated with either RNase A, and ultimately subjected to 
gentle permeabilization by repeated freeze-thaw cycles at -80 °C to permit RNase A entry into EVs. This 
permeabilization occurred before (right column) or after (left and middle columns) addition of an RNAse 
inhibitor. Analysis of EVs in each condition included RNA quantification with Agilent Bioanalyzer 2100 
and TapeStation Analysis Software 3.1.1 to quantify the RNA present within EVs (n = 2) or quantified 
with flow cytometry (n = 2). These EVs were co-incubated with Luc-WSN/33 in MDCK-SIAT1 cells and 
replication was assessed using luminescence. Data represent mean luminescence at 12 h post infection 
from individual wells normalized to control from 4 independent experiments. 
Data information: Error bars = SD. One-way ANOVA (**** p value of < 0.0001).
Figure EV3. Differential abundance of proteins within AM-EVs in response to CSE
A. Flowchart demonstrating the number proteins within each EV condition compared using TMT-
MS and each of the listed criteria. 
B. Volcano plot of all 4497 proteins identified in both EV conditions. Orange boxes collectively 
denote the proteins with significantly different relative abundance (a -log10 q value > 2) and with 
>25% difference in abundance ratio. 
C. List of the 8 proteins identified that exhibited > log2 0.33 in abundance in EVs isolated from 0.8% 
CSE-treated AMs compared to 0% CSE-treated AM-EVs. 
Figure EV4. AM-EVs inhibit Luc-WSN/33 replication within 3 h. 
Representative example of measured luminescence from Luc-WSN/33-infected MDCK-SIAT1 cells with 
(triangles) and without (squares) AM-EVs (EV:cell = 4). Curves shown from this representative 
experiment display average luminescence reads of 6 wells per condition. 
Data information: Mean AUC between curves between 0-1 h were not statistically different, whereas 
mean AUC between curves 1-3 h were significantly different (p < 0.0001, unpaired Student’s t-test). 
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To determine if DR-EVs exhibited spectral overlap with FDx, the emission intensities of DR-EVs 
(488ex/525em, top histogram) were compared to the background emission intensities (488ex/525em, 
middle histogram) within MDCK-SIAT1 cells. Using FIJI software, ROIs containing DR-EV particles 
internalized into MDCK-SIAT1 cells were defined using 647ex/700em images. These ROIs 
corresponding to DR-EVs were applied to 488ex/525em images to assess their spectral crossover into this 
emission range and their corresponding intensities were plotted (top histogram). Particles within the DR-
EV ROIs were then cleared from the 488ex/525em images. To establish the background 488ex/525em 
intensity, new ROIs with the same dimensions were applied to the remaining area within these cells and 
their associated intensities were recorded and plotted (middle histogram). These histograms show that 
DR-EVs exhibit no 488ex/525em above background (top vs. middle histogram). For comparison, 
488ex/525em intensities of FDx particles were recorded and plotted (bottom histogram). Data represent 
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